[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356835-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356835-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","dusp5-suppresses-esophageal-squamous-cell-carcinoma-by-counteracting-macrophage-derived-areg-erk12-signaling-and-disrupting-an-oncogenic-erk12-elk1-dusp5-feedback-circuitry","DUSP5 suppresses esophageal squamous cell carcinoma by counteracting macrophage-derived AREG-ERK1/2 signaling and disrupting an oncogenic ERK1/2-ELK1-DUSP5 feedback circuitry","","Dual-speciﬁcity phosphatase 5 (DUSP5) suppresses esophageal squamous cell carcinoma by disrupting a macrophage-driven AREG-ERK1/2 signaling circuit that promotes tumor growth and immune modulation. Single-cell transcriptomics identifies tumor-infiltrating APCOC⁺ macrophages communicating via AREG-EGFR to activate MAPK/ERK signaling. DUSP5 is downregulated in ESCC; restoring or overexpressing DUSP5 blocks proliferation, induces senescence and apoptosis, and suppresses migration and invasion. In xenograft and carcinogen models, DUSP5 reverts ERK1/2-driven tumor progression and identifies a DUSP5 feedback mechanism involving ELK1.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/dusp5-suppresses-esophageal-squamous-cell-carcinoma-by-counteracting-macrophage-derived-areg-erk12-signaling-and-disrupting-an-oncogenic-erk12-elk1-dusp5-feedback-circuitry/356835/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/dusp5-suppresses-esophageal-squamous-cell-carcinoma-by-counteracting-macrophage-derived-areg-erk12-signaling-and-disrupting-an-oncogenic-erk12-elk1-dusp5-feedback-circuitry/356835.png","ImageObject",300,407,{"name":42,"@type":43},"Terk","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does DUSP5 play in esophageal squamous cell carcinoma (ESCC)?","Question",{"text":63,"@type":64},"DUSP5 acts as a tumor suppressor in ESCC by inhibiting ERK1/2 activation and blocking tumor-promoting behaviors such as proliferation, migration, and invasion.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do macrophages contribute to ESCC progression in this study?",{"text":68,"@type":64},"Tumor-infiltrating APOC⁺ macrophages interact with tumor cells through the amphiregulin-EGFR (AREG-EGFR) axis, activating MAPK/ERK signaling and modulating immune responses to support tumor growth.",{"name":70,"@type":61,"acceptedAnswer":71},"How is the DUSP5–ERK1/2–ELK1 pathway connected mechanistically?",{"text":72,"@type":64},"The study identifies ELK1, a downstream ERK1/2 transcription factor, as a negative regulator of DUSP5, and shows that DUSP5 tumor-suppressive effects are reversed when ERK1/2 is activated.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356835,1790466767,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099525198933,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nDUSP5 suppresses esophageal squamous cell carcinoma by counteracting macrophage-derived AREG-ERK1/2 signaling and disrupting an oncogenic ERK1/2-ELK1-DUSP5 feedback circuitry  \nXu Huang 1,9, Wenyi Xu1,9, Runze You1,9, Junjie Kuang2,9, Kai Zhu3, Jun Li4, Jingzhang Li2, Yavuz Nuri Ertas 5,6 ✉, Qiuhong Ma7 ✉, Maojin Tian 8 ✉ and Miao Lin1 ✉  \n© The Author(s) 2026  \n|  |  |  |\n| --- | --- | --- |\n|  | Dual-speciﬁcity phosphatase 5 (DUSP5) is a key regulator of the mitogen-activated protein kinase (MAPK) pathway, with established roles in various types of cancer. However, its function in esophageal squamous cell carcinoma (ESCC) remains unclear. This study combines single-cell transcriptomics with in vitro and in vivo models to investigate the role of DUSP5 in ESCC. Single-cell RNA sequencing revealed tumor-inﬁltrating myeloid populations, including apolipoprotein C-positive (APOC⁺) macrophages, which interact with tumor cells via the amphiregulin-epidermal growth factor receptor (AREG-EGFR) axis, activating MAPK/extracellular signal-regulated kinase (ERK) signaling to promote tumor growth and immune modulation. We identiﬁed a prognostic gene signature linked to these macrophages. DUSP5 expression was downregulated in ESCC tissues, and its overexpression inhibited cell proliferation, induced senescence and apoptosis, and suppressed migration and invasion. In mouse xenografts, overexpression of DUSP5 reduced tumor growth and metastasis. Mechanistically, DUSP5 inhibited ERK1/2 activation, and its tumor-suppressive effects were reversed by ERK1/2 activation. Moreover, ETS Like-1 protein (ELK1), an ERK1/2 downstream transcription factor, was identiﬁed as a negative regulator of DUSP5 . In a carcinogen-induced model, DUSP5 knockout increased tumor burden, effects reversed by ERK1/2 inhibition. Our ﬁndings indicate that the DUSP5-ERK1/2-ELK1 signaling axis, modulated by tumor-inﬁltrating myeloid cells, |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| contributes to ESCC progression and represents a promising source of biomarkers and therapeutic targets. |  |  |\n|  | Cell Death and Disease (2026)17:498; [https://doi.org/10.1038/s41419-026-08641-0](https://doi.org/10.1038/s41419-026-08641-0) |  |\n|  |  |  |\n\nINTRODUCTION  \nEsophageal squamous cell carcinoma (ESCC) is an aggressive malignancy with unfavorable outcomes, primarily due to early metastasis and resistance to conventional treatments [1, 2] . Despite recent advances in early detection and therapeutic interventions, the molecular mechanisms underlying ESCC progression remain inadequately understood, hindering the development of effective treatment strategies [1, 3, 4] . Recent singlecell transcriptomic studies have unveiled the heterogeneity of myeloid populations within ESCC, identifying distinct macrophage subsets that interact with epithelial tumor cells and inﬂuenceoncogenic signaling pathways. Evidence suggests that dysregulation of various signaling pathways, particularly the MAPK (Mitogen-Activated Protein Kinase) pathway, is crucial in the initiation and progression of this disease [5, 6] . Among the key regulators of the MAPK pathway, dual speciﬁcity phosphatase 5 (DUSP5), extracellular signal-regulated kinase (ERK), and the transcription factor ELK1 have emerged as signiﬁcant factors  \ninﬂuencing the biological behaviors of cancer cells. These molecules are interconnected in a complex regulatory network that impacts tumor growth, metastasis, and resistance to therapy, highlighting their potential as therapeutic targets in ESCC.  \nDUSP5 is a member of the dual speciﬁcity phosphatase family, which regulates the MAPK pathway by dephosphorylating and inactivating MAPK proteins such as ERK [7, 8] . By acting as a negative regulator, DUSP5 helps to maintain cellular homeostasis and prevent unchecked cellular proliferation [9, 10] . Reduce","cbCaiaeD1vl5YV4F","https://ap.wps.com/l/cbCaiaeD1vl5YV4F","pdf",11998308,15,"English","# Introduction\n## DUSP5 and MAPK/ERK regulation in ESCC\n# Signaling interplay involving macrophage-derived AREG-EGFR\n# ERK1/2–ELK1–DUSP5 feedback circuitry\n# Study rationale and objectives","[{\"question\":\"What role does DUSP5 play in esophageal squamous cell carcinoma (ESCC)?\",\"answer\":\"DUSP5 acts as a tumor suppressor in ESCC by inhibiting ERK1/2 activation and blocking tumor-promoting behaviors such as proliferation, migration, and invasion.\"},{\"question\":\"How do macrophages contribute to ESCC progression in this study?\",\"answer\":\"Tumor-infiltrating APOC⁺ macrophages interact with tumor cells through the amphiregulin-EGFR (AREG-EGFR) axis, activating MAPK/ERK signaling and modulating immune responses to support tumor growth.\"},{\"question\":\"How is the DUSP5–ERK1/2–ELK1 pathway connected mechanistically?\",\"answer\":\"The study identifies ELK1, a downstream ERK1/2 transcription factor, as a negative regulator of DUSP5, and shows that DUSP5 tumor-suppressive effects are reversed when ERK1/2 is activated.\"}]","DUSP5 suppresses esophageal squamous cell carcinoma by counteracting macrophage-derived AREG-ERK1/2 signaling and disrupting an oncogenic ERK1/2-ELK1-DUSP5 feedback circuitry | PDF",1790127563,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5255f199e139df473e2f6ab00337d7ca.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c971e8f98ce6c42b69431972f07562e.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/65c4b6a97421a337e1e32700133e5151.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84367b4c4a6b51c44a0430965ac8dfe1.webp",980,1301]